Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
Published in Drug Law Weekly, January 22nd, 2008
Bayhill Therapeutics, Inc. ("Bayhill") announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission ("SEC") relating to the proposed initial public offering of shares of its common stock. Copies of the Bayhill registration statement on Form S-1 can be accessed over the internet through the SEC's website at edgar.sec.gov. The number of shares to be offered and the price range for the offering have not yet been determined. All of the shares of common stock to be sold in this offering are proposed to be sold by Bayhill.
Pacific Growth Equities, LLC and Lazard Capital Markets LLC are acting as joint book-running managers for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2008-01-22)
More Articles from Drug Law Weekly
- Adams Respiratory Therapeutics, Inc.
Reckitt Benckiser Receives Hart-Scott-Rodino Antitrust Clearance for Acquisition of Adams Respiratory Therapeutics - American Association for Justice
Statement from AAJ President Kathleen Flynn Peterson on ATRA's Latest Attack on Civil Justice Attorneys - Behavior
New behavior study findings have been reported by M.A. Salinger and co-researchers - Biotech Business
2008 Brings New FDA Post-Market Requirements That Demand Expert Services, Reports Watermark Research Partners - Breckenridge Pharmaceutical, Inc.
Breckenridge Pharmaceutical Settles 'Paragraph IV' Litigation and Receives FDA Approval for its Oxcarbazepine ANDA - Cancer
Federal Government Receives Failing Grades on Tobacco Control in Annual American Lung Association Report - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
